Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

NCT02717195 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02717195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02717195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2016
Completion date
October 8, 2018
Enrollment
1,098 (actual)
Sites
147

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia